These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 136669)

  • 1. A comparison of iocetamic acid and sodium iopodate in cholecystography.
    Golberg B
    Radiol Clin (Basel); 1977; 46(1):42-9. PubMed ID: 136669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical comparison of locetamic acid (cholebrine) and ipodate sodium (Orgrafin).
    Neal RR; Harvey KG; Cantwell KG; Press HC
    AJR Am J Roentgenol; 1979 May; 132(5):735-6. PubMed ID: 155391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of diet and fasting on gallbladder opacification during oral cholecystography in dogs as measured by computed tomography.
    Fon GT; Hunter TB; Berk RN; Capp MP
    Radiology; 1980 Sep; 136(3):585-92. PubMed ID: 7403534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical comparison of tyropanoate sodium, ipodate sodium, and iopanoic acid.
    Russell JG; Frederick PR
    Radiology; 1974 Sep; 112(3):519-23. PubMed ID: 4843279
    [No Abstract]   [Full Text] [Related]  

  • 5. Sodium taurocholate, ineffective as an adjuvant in oral cholecystography.
    Katevuo K; Kormano M
    Radiologe; 1982 Jan; 22(1):32-3. PubMed ID: 7063664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Recent triiodinated contrast media for oral cholecystocholangiography].
    Sviridov NK; Popova ZP; Varfolomeeva VN
    Med Radiol (Mosk); 1985 Feb; 30(2):58-60. PubMed ID: 3155821
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical comparison of two contrast agents for oral cholecystography: radiologic efficacy and drug safety of iopanoic acid and iopronic acid.
    Hedlund L; Putman CE; Burrell M
    Yale J Biol Med; 1979; 52(3):257-62. PubMed ID: 380184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparative trial of three oral cholecystographic contrast media--iocetamic acid, iopanoic acid and sodium ipodate.
    Cargill A; Hately W
    Br J Radiol; 1981 Jan; 54(637):79-80. PubMed ID: 6449974
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparative study of iocetamic acid and calcium ipodate in the visualisation of the gallbladder and common bile duct.
    Owen JP; Lavelle MI
    Clin Radiol; 1978 Sep; 29(5):535-40. PubMed ID: 152180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the opacifying characteristics and pharmacologic responses of iocetamic acid (Cholebrine), a new oral cholecystographic agent, with sodium tyropanoate (Bilopaque).
    Wishart DL; Dotter CT
    Am J Roentgenol Radium Ther Nucl Med; 1973 Oct; 119(2):429-32. PubMed ID: 4748234
    [No Abstract]   [Full Text] [Related]  

  • 11. The effect of fractionated administration of locetamic acid (Cholebrine) on gallbladder visualization.
    Michal JA; Nelson JA; Koehler PR
    Radiology; 1976 Jun; 119(3):537-8. PubMed ID: 132679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Evaluation of the results of a clinical study of the x-ray specific activity of the Soviet x-ray contrast medium bilimin, intended for peroral cholecystography and cholecystocholangiography].
    Rozenshtraukh LS; Rabkin IKh; Absava GI
    Vestn Rentgenol Radiol; 1985; (2):19-23. PubMed ID: 4013059
    [No Abstract]   [Full Text] [Related]  

  • 13. [The effect of diarrhea on gallbladder opacification during oral cholecystography: comparison of two cholecystographic agents (author's transl)].
    Fukuda K; Nanjo M; Harada J; Sekiya T; Kanehira Y; Anno I; Takayama M; Watanabe H; Yamada T; Yamaguchi M; Tada S
    Rinsho Hoshasen; 1979 Mar; 24(3):379-84. PubMed ID: 547079
    [No Abstract]   [Full Text] [Related]  

  • 14. Double-blind study of four oral cholecystographic preparations.
    Parks RE
    Radiology; 1974 Sep; 112(3):525-8. PubMed ID: 4602064
    [No Abstract]   [Full Text] [Related]  

  • 15. [Initial experience with the Soviet preparation, biloptin, for oral cholecystocholangiography].
    Popova ZP; Ushakov VL; Sviridov NK
    Vestn Rentgenol Radiol; 1979; (2):23-7. PubMed ID: 375563
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical and chemical aspects of residual contrast media in the intestine during oral cholecystography with Trijobil and Falignost].
    Quasdorf M; Becker C; Quasdorf G; Becker HW
    Radiol Diagn (Berl); 1977; 18(1):19-28. PubMed ID: 866607
    [No Abstract]   [Full Text] [Related]  

  • 17. [Comparative study with a closed sequential design between iopronic and iocetamic acid in oral cholecystocholangiography with radiograms in short and standard times. Laboratory evaluation of hepatic function (author's transl)].
    Lutman M; Morassut S; Bigai M; Galassi G; Galofaro G; Piazza P
    Radiol Med; 1980; 66(7-8):517-22. PubMed ID: 6452657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Time of optimal gallbladder opacification with bilopaque (tyropanoate sodium).
    Oliphant M; Whalen JP; Evans JA
    Radiology; 1974 Sep; 112(3):531-2. PubMed ID: 4843281
    [No Abstract]   [Full Text] [Related]  

  • 19. Use of oral cholecystography agents in the treatment of hyperthyroidism of subacute thyroiditis.
    Martinez DS; Chopra IJ
    Panminerva Med; 2003 Mar; 45(1):53-7. PubMed ID: 12682620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The combined use of oral cholecystopaque media and iodipamide.
    Goergen T; Goldberger LE; Berk RN
    Radiology; 1974 Jun; 111(3):543-8. PubMed ID: 4828985
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.